STYLOS
LIVE

Serial Number

99328824

Owner

Stylos Health, LLC

Filing Date

Aug 8, 2025

Add to watchlist:

No watchlists yet
View on USPTO

STYLOS Trademark

Serial Number: 99328824

STYLOS is a trademark filed by Stylos Health, LLC on August 8, 2025. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Stylos Health, LLC

2807 Allen Street, PMB 390
Dallas, TX 75204

Entity Type: 16

Trademark Details

Filing Date

August 8, 2025

Registration Date

Not Registered

Goods & Services

Downloadable mobile applications and downloadable computer software for use as a personal health data repository, namely, for consolidating, storing, organizing, and displaying health data from multiple sources; downloadable software for calculating biological age scores from aggregated laboratory test results, wearable device data, genetic test data, and lifestyle factors; downloadable software for importing and parsing laboratory test results, genetic test data, and pharmacogenomic data from third-party sources; downloadable software for aggregating and displaying health metrics from wearable fitness devices and wellness applications; downloadable software for tracking health interventions, supplements, and medications; downloadable software for tracking participation in health challenges and displaying health-related achievements; downloadable software providing educational information about pharmacogenomic drug-gene interactions and genetic factors affecting health and wellness optimization; downloadable software featuring artificial intelligence for analyzing health data and providing optimization suggestions.

Providing health information in the field of longevity and biological age optimization, namely, providing information about how laboratory test results, wearable device metrics, genetic factors, and lifestyle choices affect biological age; providing educational information about pharmacogenomic drug-gene interactions, genetic factors affecting health and wellness optimization, and biomarker optimal ranges; facilitating user-initiated access to third-party laboratory testing services by transmitting orders between consumers and third-party laboratory test providers.

Software as a service (SAAS) services featuring software for use as a personal health data repository for consolidating and organizing health data from multiple sources; SAAS services featuring software for calculating and displaying biological age scores derived from laboratory test results, wearable device metrics, genetic test data, and lifestyle factors; application service provider (ASP) services featuring software for aggregating health data from multiple third-party sources into a unified health dashboard; providing temporary use of online non-downloadable software for tracking health interventions, supplements, and medications; providing temporary use of online non-downloadable software for tracking participation in health challenges and social wellness activities; providing temporary use of online non-downloadable software providing educational information about pharmacogenomic drug-gene interactions and genetic factors affecting health and wellness optimization; providing temporary use of online non-downloadable software featuring artificial intelligence for analyzing aggregated health data and generating optimization suggestions; providing application programming interface (API) software for importing health data from laboratory information systems, wearable device platforms, and wellness application platforms.

Filing History

TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 25, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 25, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 25, 2026 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Mar 19, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Mar 19, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jan 6, 2026 CNRT
ASSIGNED TO EXAMINER
Dec 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 18, 2025 NWOS
APPLICATION FILING RECEIPT MAILED
Aug 8, 2025 MAFR
NEW APPLICATION ENTERED
Aug 8, 2025 NWAP